Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-041260
Filing Date
2025-03-18
Accepted
2025-03-18 16:30:11
Documents
2
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1642
2 EX-24.1 mnmd-ex24_1.htm EX-24.1 11862
  Complete submission text file 0000950170-25-041260.txt   15011
Mailing Address C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN ST, WEIZMANN SCIENCE PARK REHOVOT L3 7670402
Business Address
Wiley Matthew T. (Reporting) CIK: 0001759703 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40360 | Film No.: 25748865

Mailing Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007 212-220-6633
Mind Medicine (MindMed) Inc. (Issuer) CIK: 0001813814 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)